Kobayashi Pharmaceutical Co., Ltd. / Fundamentals
Income statement
- Net revenue
€920.44M - Cost of goods sold
€448.16M - Gross profit
€470.23M - SG&A expenses
€244.75M - R&D expenses
€64.45M - EBITDA
€134.65M - D&A
€21.55M - EBIT
€127.31M - Interest expenses
€159.36K - EBT
€80.09M - Tax expenses
€19.08M - Net income
€60.98M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€60.98M - Changes in working capital
€0.00 - Operating cash flow
€0.00 - Capex
€0.00 - Other investing cash flow
€0.00 - Net investing cash flow
€0.00 - Total cash dividends paid
€0.00 - Issuance of common stock
€0.00 - Debt repayment
€0.00 - Other financing cash flow
€0.00 - Net financing cash flow
€0.00 - Foreign exchange effects
€0.00 - Net change in cash
€0.00 - Cash at end of period
€0.00 - Free cash flow
€0.00
Balance sheet
- Cash and cash equivalents
€298.26M - Cash and short-term investments
€382.92M - Total receivables
€185.40M - Inventory
€155.89M - Other current assets
€28.96M - Total current assets
€753.17M - Property, plant & equipment
€385.12M - Goodwill
€47.84M - Intangible assets
€60.57M - Long-term investments
€160.30M - Other non-current assets
€6.37M - Total non-current assets
€679.68M - Total assets
€1.43B - Accounts payable
€86.22M - Short-term debt
€2.07M - Other current liabilities
€137.58M - Total current liabilities
€225.86M - Long-term debt
€2.42M - Deferred tax liabilities
€6.73M - Other non-current liabilities
€19.34M - Total non-current liabilities
€28.50M - Total liabilities
€254.36M - Common stock
€19.64M - Retained earnings
€1.17B - Other equity
€127.31M - Total equity
€1.18B - Total liabilities and shareholders' equity
€1.43B
Company information
- Market capitalization
€2.34B - Employees
3.6K - Enterprise Value
€367.43B
Company ratios
- Gross margin
-
51.1% Worse than peer group: 58.7% - EBITDA margin
-
14.6% Even with peer group: 14.4% - EBIT margin
-
13.8% Even with peer group: 10.4% - EBT margin
-
8.7% Even with peer group: 10.1% - Net margin
-
6.6% Even with peer group: 6.2% - ROE
-
5.2% Even with peer group: 8.9% - ROA
-
4.3% Even with peer group: 5.5% - Asset turnover
-
64.2% Much worse than peer group: 89.1% - FCF margin
-
0.0% - FCF yield
0.0% - Efficiency ratio
85.4% - Net sales per employee
-
€254.62K - Net income per employee
-
€16.87K